On the 31st, the biosimilar (generic biopharmaceutical) theme showed strength, rising 3.24% compared to the previous day, while Vynex, a related stock drawing attention, surged 25.12% compared to the previous day. Vynex is known as a pharmaceutical specialist company.


[Graph] Major stock price changes in the biosimilar (generic biopharmaceutical) theme




According to the analysis by Thinkpool Robo Algorithm RASSI, Vynex ranked 4th out of 17 stocks in the quant financial ranking by exceeding the theme’s average scores in growth, stability, and profitability. This can be interpreted as Vynex having relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.


[Table] Top stocks by financial score within the theme



※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.


※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


Hot Picks Today

"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ① "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①





한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing